Nabarro advises Numis on £25.5m placing to raise additional capital for Retroscreen
Nabarro is advising existing client Numis Securities on a £25.5m placing to raise additional capital for AIM-traded Retroscreen Virology.
Retroscreen conducts research into antiviral drugs and vaccines through the use of its ‘Viral Challenge Model’, which involves infecting healthy human volunteers with a virus under controlled conditions.
The Nabarro team advising Numis in its capacity as nomad and broker for Retroscreen was led by corporate partner Alasdair Steele, assisted by senior associate Jack Shepherd and trainee Nikita Arora.
News from Nabarro
Briefings from Nabarro
The Safe Harbor scheme is of key importance to transatlantic trade.
Mr Mitchell’s solicitors have been denied the ability to recover costs, estimated to be in excess of £500,000, because they failed to file a costs budget on time.
Analysis from The Lawyer
Real estate continues to be the key money spinner for Nabarro, which has always been known for its work in the UK property market, (although) last year results were up across the firm. Google’s ...
A few UK200 firms – such as DWF – have managed to grow in the downturn. A few, such as Berwin Leighton Paisner, have come back stronger than ever after a wobble. Nabarro fits into neither category.